GW Pharmaceuticals



GW Pharmaceuticals is a British biopharmaceutical company known for its multiple sclerosis treatment product nabiximols which was the first natural cannabis plant derivative to gain market approval in any country.

Chris Tovey
Chief Operating Officer
Darren Cline
U.S. Chief Commercial Officer
Douglas Snyder
Chief Legal Officer
Scott Giacobello
Chief Financial Officer
Tina St. Leger
Chief Human Resources Officer
Volker Knappertz
Chief Medical Officer

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.